Month: July 2020

HONG KONG, SHANGHAI, and FLORHAM PARK, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) and Eli Lilly and Company (“Lilly”) today announce an amendment to the 2013 License and Collaboration Agreement on Fruquintinib with Lilly Shanghai, an affiliate of Lilly.  The 2020 Amendment covers the expansion of Chi-Med’s role in the commercialization of Elunate® (fruquintinib capsules) in China.Under the terms of the 2020 Amendment, Lilly will maintain the exclusive commercialization rights, and as a consequence, will continue to consolidate the sales of Elunate® in China.  Chi-Med will collaborate with Lilly in commercializing Elunate® across China.In a joint statement, Mr. Christian Hogg, CEO of Chi-Med and Mr. Julio Gay-Ger, President & General Manager, Lilly China, said “After...

 FIRST-HALF 2020 RESULTSSAME-DAY SALES DOWN -17.7% IN Q2 20, WITH GRADUAL RECOVERY SINCE APRILACTIVE OPEX MANAGEMENT IN Q2, WITHOUT COMPROMISING OUR MEDIUM-TERM DIGITAL AMBITIONSTRONG FCF GENERATION WITH A 77.7% CONVERSION RATE IN H1 2020→ SALES OF €2,820.4m IN Q2 2020, REFLECTING BUSINESS CONTINUITY TO SERVE OUR CUSTOMERS WHILE PRESERVING THE HEALTH AND SAFETY OF OUR EMPLOYEESOn a constant and same-day basis, sales down 17.7% in Q2 20. Even as the COVID-19 pandemic spread in most geographies, the dedication of our employees and digital transformation allowed us to gain market shareGradual improvement since April, with progressive recovery in Europe and Pacific, while North America is lagging Same-day sales down 5.6% in the first 2 weeks of July→ FOCUS ON PROFITABILITY WITH REAL-TIME ADAPTATION TO EVERY LOCAL SITUATION; SALARY &...

RESULTATS DU 1er SEMESTRE 2020VENTES A JOURS CONSTANTS EN BAISSE DE -17,7% AU T2 20, AMÉLIORATION PROGRESSIVE DEPUIS AVRILGESTION ACTIVE DES OPEX AU T2, SANS COMPROMETTRE NOS AMBITIONS DIGITALES A MOYEN TERMEFORTE GÉNÉRATION DE FCF AVEC UN TAUX DE CONVERSION DE 77,7% AU S1 2020→ VENTES DE 2 820,4M€ AU T2 2020, REFLÉTANT LA CONTINUITÉ DE NOS ACTIVITÉS AU SERVICE DE NOS CLIENTS TOUT EN PRÉSERVANT LA SANTÉ ET LA SÉCURITÉ DE NOS EMPLOYÉSEn données comparables et à nombre de jours constant, les ventes sont en baisse de 17,7% au T2 2020. Alors que la pandémie de Covid-19 se propageait dans la majorité de nos pays, le dévouement de nos employés et notre transformation digitale nous ont permis de gagner des parts de marchéAmélioration progressive depuis avril, avec une reprise graduelle en Europe et dans le Pacifique, tandis que l’Amérique du...

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2020MADE AVAILABLERexel’s condensed consolidated interim financial statements as of June 30, 2020 was filed on July 28th 2020 with the French Autorité des marches financiers (AMF).They are also made available on Rexel’s corporate website (https://www.rexel.com/en) in the “Investors –Regulated Information” section.ABOUT REXEL GROUPRexel, worldwide expert in the multichannel professional distribution of products and services for the energy world, addresses three main markets – residential, commercial and industrial. The Group supports its residential, commercial and industrial customers by providing a tailored and scalable range of products and services in energy management for construction, renovation, production and maintenance.Rexel operates through a network of...

___________________________________________________________________________________________MISE A DISPOSITIONDES ETATS FINANCIERS CONSOLIDES INTERMEDIAIRES RESUMES AU 30 JUIN 2020_______________________________________________________________________________________Les états financiers consolidés intermédiaires résumés au 30 juin 2020 de Rexel ont été déposés auprès de l’Autorité des marchés financiers (AMF) le 28 juillet 2020.Ils sont également consultables sur le site internet de Rexel (https://www.rexel.com/fr) dans la rubrique « Investisseurs – Information réglementée »AU SUJET DU GROUPE REXELRexel, expert mondial de la distribution professionnelle multicanale de produits et services pour le monde de l’énergie, est présent sur trois marchés : résidentiel, tertiaire et industriel. Le Groupe accompagne ses clients pour leur permettre...

Company announcement No. 19/2020July 28, 2020Chr. Hansen Holding A/S (“Chr. Hansen”) today announced that it has successfully completed the acquisition of UAS Laboratories LLC (“UAS Labs”) following the satisfaction of all closing conditions.With UAS Labs, Chr. Hansen further strengthens its microbial platform and Human Health business by moving into the highly attractive space of multi-species, high-potency blends and broadening its product offering and customer base. Furthermore, Chr. Hansen is expanding its manufacturing footprint with two GMP facilities in the United States which will allow phasing of capex projects over the coming years and reduce enterprise risk.Mauricio Graber, Chief Executive Officer of Chr. Hansen, said: “With closing of the UAS Labs acquisition, we look forward to building upon the strengths of both companies....

Arcadis nominates Virginie Duperat–Vergne as new CFO and member of the Executive BoardPeter Oosterveer available for re-appointment as CEO in 2021Amsterdam, 28 July 2020 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announces that its Supervisory Board has nominated Virginie Duperat-Vergne (1975) for the position of Chief Financial Officer and member of the Executive Board, as the successor to Sarah Kuijlaars, who left Arcadis effective 4 March, 2020.The Supervisory Board is also pleased to announce that Peter Oosterveer remains available for re-appointment as CEO when his current term expires in 2021. This ensures that Arcadis is led by an experienced and talented team with a long-term commitment to deliver upon the strategy for 2021-2023 to be announced in...